WallStreetZenWallStreetZen

NASDAQ: ELOX
Eloxx Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ELOX stock forecasts and price targets.

Forecast return on equity

Is ELOX forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is ELOX forecast to generate an efficient return on assets?

Company
-111.72%
Industry
-32.96%
ELOX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ELOX earnings per share forecast

What is ELOX's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$8.00

ELOX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ELOX$11.01N/AN/A
JSPR$0.47$3.83+722.53%Hold
CYCN$3.00N/AN/A
CMMB$1.73N/AN/A
MBRX$2.41$22.00+812.86%Buy
View Top Biotech Stocks

Eloxx Pharmaceuticals Stock Forecast FAQ

What is ELOX's earnings growth forecast for 2026-2026?

(NASDAQ: ELOX) Eloxx Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Eloxx Pharmaceuticals's earnings in 2026 is N/A.

In 2026, ELOX is forecast to generate -$9,499,255 in earnings, with the lowest earnings forecast at -$9,126,735 and the highest earnings forecast at -$9,778,645.

If you're new to stock investing, here's how to buy Eloxx Pharmaceuticals stock.

What is ELOX's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: ELOX) forecast ROE is N/A, which is considered weak.

What is ELOX's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: ELOX) Eloxx Pharmaceuticals's current Earnings Per Share (EPS) is N/A. In 2026, ELOX's EPS is forecast to hit -$8.00 (min: -$7.68, max: -$8.23).

What is ELOX's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: ELOX) forecast ROA is -111.72%, which is lower than the forecast US Biotechnology industry average of -32.96%.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.